(Q53984387)

23 May 2018

title

Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. (English)

1 reference

23 May 2018

1 reference

Litwin A

1

1 reference

23 May 2018

Flanagan M

2

1 reference

23 May 2018

Entis G

3

1 reference

23 May 2018

Gottschlich G

4

1 reference

23 May 2018

Esch R

5

1 reference

23 May 2018

Gartside P

6

1 reference

23 May 2018

Michael JG

7

1 reference

23 May 2018

publication date

1 August 1996

1 reference

23 May 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

23 May 2018

volume

77

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

page(s)

132-138

1 reference

23 May 2018

Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Immunotherapy for cat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

A controlled trial of immunotherapy in insect hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Oral immunotherapy in birch pollen hay fever

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Oral immunotherapy with grass pollen in enterosoluble capsules. A prospective study of the clinical and immunological response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Safety and efficacy of oral immunotherapy with standardized cat extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Comparative performance of five commercial prick skin test devices

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Regulation of the human immune response to ragweed pollen by immunotherapy. A controlled trial comparing the effect of immunosuppressive peptic fragments of short ragweed with standard treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Oral hyposensitisation with enteric-coated allergens as extension therapy following a basic subcutaneous course of injections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Immunotherapy: parameters of assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Systemic reactions from allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

Dose response of IgE and IgG antibodies during ragweed immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963499-0

7 January 2021

10.1016/S1081-1206(10)63499-0

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

8760779

1 reference

23 May 2018